Lung cancer is by far the most common cause of cancer death in the UK. It is a common condition typically presented at a late stage. Late diagnosis of lung cancer is a leading cause of poor cancer survival outcomes in the UK.
RM Partners data analysis revealed areas within west London of high incidence of lung cancer; low rates of diagnosis at the early stages of lung cancer (stages 1 and 2); high rates of diagnosis at stage 4, and low one-year survival rates for patients with lung cancer.
We are supporting three projects to improve earlier diagnosis of lung cancer across west London.
- The Targeted Lung Health Check (TLHC) project takes a proactive approach by detecting cancer at an early stage in patients who are asymptomatic.
- The local implementation of the National Optimal Lung Cancer Pathway (NOLCP) aims to improve the delivery of reactive diagnostic pathways once patients are symptomatic.
-
The management of pulmonary nodule project aims to standardise approaches to improving prompt diagnosis of cancerous nodules and improving patient experience.
Targeted Lung Health Check Project